MXEBX
Price
$15.72
Change
-$0.19 (-1.19%)
Updated
Jun 13 closing price
Net Assets
652.18M
RWEBX
Price
$61.59
Change
-$0.63 (-1.01%)
Updated
Jun 13 closing price
Net Assets
194.44B
Interact to see
Advertisement

MXEBX vs RWEBX

Header iconMXEBX vs RWEBX Comparison
Open Charts MXEBX vs RWEBXBanner chart's image
Empower Core Strategies US Eq Instl
Price$15.72
Change-$0.19 (-1.19%)
VolumeN/A
Net Assets652.18M
American Funds Washington Mutual R2E
Price$61.59
Change-$0.63 (-1.01%)
VolumeN/A
Net Assets194.44B
MXEBX vs RWEBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MXEBX vs. RWEBX commentary
Jun 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MXEBX is a StrongBuy and RWEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RWEBX has more cash in the bank: 194B vs. MXEBX (652M). MXEBX pays higher dividends than RWEBX: MXEBX (1.66) vs RWEBX (0.80). MXEBX was incepted earlier than RWEBX: MXEBX (7 years) vs RWEBX (11 years). RWEBX (1.06) is less costly to investors than MXEBX (0.71). RWEBX is a more actively managed with annual turnover of: 31.00 vs. MXEBX (20.00). MXEBX has a lower initial minimum investment than RWEBX: MXEBX (0) vs RWEBX (250). RWEBX annual gain was more profitable for investors over the last year : 3.84 vs. MXEBX (1.74). MXEBX return over 5 years is better than : 66.60 vs. RWEBX (47.99).
MXEBXRWEBXMXEBX / RWEBX
Total Expense Ratio0.551.0652%
Annual Report Gross Expense Ratio0.711.0667%
Fund Existence7 years11 years-
Gain YTD1.2231.116110%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets652M194B0%
Annual Yield % from dividends1.660.80209%
Returns for 1 year1.743.8445%
Returns for 3 years48.3722.59214%
Returns for 5 years66.6047.99139%
Returns for 10 yearsN/A56.01-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CDP28.60-0.16
-0.56%
COPT Defense Properties
VMEO4.24-0.07
-1.62%
Vimeo
IKT1.86-0.05
-2.62%
Inhibikase Therapeutics
BDRX1.07-0.03
-2.73%
Biodexa Pharmaceuticals plc
BRKR38.30-1.57
-3.94%
Bruker Corp